Literature DB >> 10449497

Phenotypic and genetic characterization of a novel Borrelia burgdorferi sensu lato isolate from a patient with lyme borreliosis.

G Wang1, A P van Dam, J Dankert.   

Abstract

Borrelia burgdorferi sensu lato A14S was cultured from a skin biopsy specimen of a patient with erythema migrans in The Netherlands. This isolate had a unique DNA fingerprint pattern compared to 135 other B. burgdorferi sensu lato isolates. In this study, the isolate A14S was further characterized by protein analysis with sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and reactivity with various monoclonal antibodies. In addition, the 16S rRNA, ospA, and ospC genes, as well as the 5S-23S rRNA intergenic spacer DNA, were amplified by PCR, cloned, and sequenced. SDS-PAGE protein profiles and phylogenetic analysis based on all of the analyzed genes confirmed that B. burgdorferi sensu lato A14S was phenotypically and genetically different from the three human pathogenic species B. burgdorferi sensu stricto, Borrelia garinii, and Borrelia afzelii, as well as from other B. burgdorferi sensu lato species. Our findings indicate that Borrelia genomic groups or isolates other than the three well-known human pathogenic species may also cause human Lyme borreliosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10449497      PMCID: PMC85444     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Clinical findings for patients with Lyme borreliosis caused by Borrelia burgdorferi sensu lato with genotypic and phenotypic similarities to strain 25015.

Authors:  F Strle; R N Picken; Y Cheng; J Cimperman; V Maraspin; S Lotric-Furlan; E Ruzic-Sabljic; M M Picken
Journal:  Clin Infect Dis       Date:  1997-08       Impact factor: 9.079

2.  Characterization of Borrelia lusitaniae sp. nov. by 16S ribosomal DNA sequence analysis.

Authors:  A Le Fleche; D Postic; K Girardet; O Peter; G Baranton
Journal:  Int J Syst Bacteriol       Date:  1997-10

3.  Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis.

Authors:  G Baranton; D Postic; I Saint Girons; P Boerlin; J C Piffaretti; M Assous; P A Grimont
Journal:  Int J Syst Bacteriol       Date:  1992-07

4.  Borrelia burgdorferi is clonal: implications for taxonomy and vaccine development.

Authors:  D E Dykhuizen; D S Polin; J J Dunn; B Wilske; V Preac-Mursic; R J Dattwyler; B J Luft
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

5.  Diversity of Borrelia burgdorferi sensu lato evidenced by restriction fragment length polymorphism of rrf (5S)-rrl (23S) intergenic spacer amplicons.

Authors:  D Postic; M V Assous; P A Grimont; G Baranton
Journal:  Int J Syst Bacteriol       Date:  1994-10

6.  Expanded diversity among Californian borrelia isolates and description of Borrelia bissettii sp. nov. (formerly Borrelia group DN127).

Authors:  D Postic; N M Ras; R S Lane; M Hendson; G Baranton
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

7.  Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation.

Authors:  T G Schwan; W Burgdorfer; C F Garon
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

8.  Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis.

Authors:  M M Canica; F Nato; L du Merle; J C Mazie; G Baranton; D Postic
Journal:  Scand J Infect Dis       Date:  1993

9.  Genomic analysis of Borrelia japonica sp. nov. isolated from Ixodes ovatus in Japan.

Authors:  H Kawabata; T Masuzawa; Y Yanagihara
Journal:  Microbiol Immunol       Date:  1993       Impact factor: 1.955

10.  Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis.

Authors:  A P van Dam; H Kuiper; K Vos; A Widjojokusumo; B M de Jongh; L Spanjaard; A C Ramselaar; M D Kramer; J Dankert
Journal:  Clin Infect Dis       Date:  1993-10       Impact factor: 9.079

View more
  33 in total

1.  Whole-genome sequences of Borrelia bissettii, Borrelia valaisiana, and Borrelia spielmanii.

Authors:  Steven E Schutzer; Claire M Fraser-Liggett; Wei-Gang Qiu; Peter Kraiczy; Emmanuel F Mongodin; John J Dunn; Benjamin J Luft; Sherwood R Casjens
Journal:  J Bacteriol       Date:  2012-01       Impact factor: 3.490

2.  In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease.

Authors:  Kristina Morgenstern; Georg Baljer; Douglas E Norris; Peter Kraiczy; Christa Hanssen-Hübner; Klaus-Peter Hunfeld
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

3.  Determination of novel Borrelia genospecies in Swedish Ixodes ricinus ticks.

Authors:  Carl-Johan Fraenkel; Ulf Garpmo; Johan Berglund
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

4.  Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi.

Authors:  Corinna Siegel; Teresia Hallström; Christine Skerka; Hannes Eberhardt; Barbara Uzonyi; Tobias Beckhaus; Michael Karas; Reinhard Wallich; Brian Stevenson; Peter F Zipfel; Peter Kraiczy
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

5.  Differentiation of reinfection from relapse in recurrent Lyme disease.

Authors:  Robert B Nadelman; Klára Hanincová; Priyanka Mukherjee; Dionysios Liveris; John Nowakowski; Donna McKenna; Dustin Brisson; Denise Cooper; Susan Bittker; Gul Madison; Diane Holmgren; Ira Schwartz; Gary P Wormser
Journal:  N Engl J Med       Date:  2012-11-15       Impact factor: 91.245

6.  Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease.

Authors:  Gary P Wormser; Dustin Brisson; Dionysios Liveris; Klára Hanincová; Sabina Sandigursky; John Nowakowski; Robert B Nadelman; Sara Ludin; Ira Schwartz
Journal:  J Infect Dis       Date:  2008-11-01       Impact factor: 5.226

7.  Borrelia burgdorferi complement regulator-acquiring surface protein 2 (CspZ) as a serological marker of human Lyme disease.

Authors:  Peter Kraiczy; Annekatrin Seling; Catherine A Brissette; Evelyn Rossmann; Klaus-Peter Hunfeld; Tomasz Bykowski; Logan H Burns; Matthew J Troese; Anne E Cooley; Jennifer C Miller; Volker Brade; Reinhard Wallich; Sherwood Casjens; Brian Stevenson
Journal:  Clin Vaccine Immunol       Date:  2007-12-26

8.  Borrelia lusitaniae OspA gene heterogeneity in Mediterranean basin area.

Authors:  Elena Grego; Luigi Bertolotti; Simone Peletto; Giuseppina Amore; Laura Tomassone; Alessandro Mannelli
Journal:  J Mol Evol       Date:  2007-09-26       Impact factor: 2.395

Review 9.  Complement regulator-acquiring surface proteins of Borrelia burgdorferi: Structure, function and regulation of gene expression.

Authors:  Peter Kraiczy; Brian Stevenson
Journal:  Ticks Tick Borne Dis       Date:  2012-11-10       Impact factor: 3.744

10.  European Hedgehogs as Hosts for Borrelia spp., Germany.

Authors:  Jasmin Skuballa; Rainer Oehme; Kathrin Hartelt; Trevor Petney; Thomas Bücher; Peter Kimmig; Horst Taraschewski
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.